Paul Jorgensen

Paul Jorgensen

ID: 1b839954-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

First trial judgment under new PMNOC Regulations declares claims to biologic drug invalid

Pharma in Brief · April 21, 2020

Federal Court rejects the concept of “first mover advantage” for generics in PM(NOC) infringement actions

Pharma in Brief · November 7, 2019

Federal Court grants application under the old PM(NOC) Regulations for a prohibition order regarding a metformin formulation

Pharma in Brief · March 25, 2019

First motion for early patent dismissal fails to meet high burden under newly-amended PM(NOC) Regulations

Pharma in Brief · July 30, 2018

FCA upholds damage award based on Teva’s infringing sales of levofloxacin

Pharma in Brief · February 14, 2018

Practice Areas

Health Care and Life Sciences

Jurisdictions